International Chinese Covid-19 vaccine maker gets $500 million funding boost

Chinese Covid-19 vaccine maker gets $500 million funding boost

Author

Date

Category

- Advertisement -

Chinese pharmaceutical firm Sinovac Biotech has secured half a billion dollars in extra funding to produce its Covid-19 vaccine, it said Monday, as the country races to roll out a jab for general use.

Beijing has largely brought the virus under control, with only 281 active cases still receiving treatment, according to official figures.

But it has promised to make its vaccines available as a “global public good” as it seeks to counter global criticism for its early handling of the pandemic.

Sino Biopharmaceutical Limited, a Hong Kong-listed medical research firm, said on Monday that it will invest $515 million for the development and production of CoronaVac, one of Sinovac’s most advanced vaccine candidates.

- Advertisement -

Sinovac — one of China’s leading vaccine producers — said the funding will be used for the “further development, capacity expansion and manufacturing” of CoronaVac.

It added it hoped to be able to manufacture 600 million doses by the end of the year.

Sino Biopharmaceutical will receive a 15 percent share in a Sinovac subsidiary, Sinovac Life Sciences, under the agreement.

Although regulators have yet to approve China’s vaccines for mass distribution, the country has approved some advanced candidates for emergency use. Since July a range of people from state employees to international students have been given jabs.

CoronaVac is being tested in multiple countries including Brazil, where final-stage clinical trials for the jab have restarted after hitting a setback in November when a volunteer experienced an “adverse incident.”

The vaccine “has reached critical milestones in clinical trials in Asia and Latin America,” Sinovac CEO Yin Weidong said in the statement.

The company earlier said almost all its employees and their families have voluntarily taken the vaccine.

Sinopharm, another Chinese vaccine maker, said in November that nearly a million people have already taken its experimental Covid-19 vaccine.

Last week Britain became the first Western country to approve a vaccine for general use, piling pressure on other countries to follow suit swiftly.

© Agence France-Presse

- Advertisement -

Man whose mother was a hawker has tough question on hawkerpreneurship cert

Singapore -- A man whose mother was a hawker has a tough question on the new Work-Study Post-Diploma (Certificate in Hawkerpreneurship): “Who would want to send their children to the polytechnic and ITE for a diploma in 'hawkerpreneurhip', only to slog...

As India battles Covid-19, staying indoors is the new normal for student

Sitamarhi (India) -- With the start of a vaccination programme against Covid-19 in India on Saturday (Jan 16), another firm step is being taken in the battle against the virus in the country. The Covid-19 pandemic has affected the daily life of...

“Eh, don’t block the road guys, please” — Motorist tells cyclists confronting cabby

Singapore -- A video has gone viral of a group of cyclists who are confronting a taxi driver being told not to block the road by the motorist behind them. On Friday (Jan 15), Facebook page ROADS.sg uploaded dashboard camera footage taken...